The civic record
Read. Follow. Verify.Massachusetts bill adds opioid maintenance treatment data to prescription monitoring program
Last action · February 26, 2026: Accompanied a study order, see S2972Sponsors: John Keenan and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
The Massachusetts legislature is considering a bill that requires the department to include information in the and mandates that treatment facilities offer patients a voluntary consent form upon intake and discharge.
Licensed prescribers will gain access to a patient's history before issuing new opioid prescriptions, provided the disclosure complies with privacy laws and patients voluntarily consent.
- Prescription monitoring programs are state-run electronic databases used by clinicians and pharmacists to track controlled substance prescriptions and help prevent misuse. context
- Senate Bill 1406 was filed in the 195th session of the Massachusetts General Court under the committee jurisdiction of Mental Health, Substance Use and Recovery. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Licensed professionals authorized to prescribe controlled substances
Prescribers will receive patient information regarding opioid maintenance treatment participation before issuing new opioid prescriptions.
Individuals entering opioid treatment programs
Patients will be presented with a form upon intake and discharge allowing them to consent to the release of their treatment information.
Opioid treatment facilities
Facilities must present consent and informational forms to individuals entering or leaving treatment and maintain records of their election.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Is consenting to share opioid maintenance treatment information mandatory?
When are patients asked to sign the consent form?
Who will have access to the prescription monitoring program information?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
5 actions- Feb 26, 2026SenateAccompanied a study order, see S2972
- Jan 12, 2026SenateCommitteeBill reported favorably by committee and referred to the committee on Health Care Financing
- Oct 24, 2025JointHearing scheduled for 11/03/2025 from 01:00 PM-05:00 PM in A-2
- Feb 27, 2025HouseHouse concurred
- Feb 27, 2025SenateCommitteeReferred to the committee on Mental Health, Substance Use and Recovery
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Study Order Linkage
The bill's latest legislative action notes that it accompanied a study order, reference S2972.
Connected Entities
Sources
malegislature.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy35Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools